R&D A playbook for effective sponsor/CRO partnership Find out more about optimising sponsor/CRO collaboration in an interview on a case study in FI cell therapy.
R&D Why pharma’s future may run through your local blood centre With demand for cell and gene therapies (CGTs) growing rapidly, blood centres are indispensable collaborators.
R&D Perspectives in viral clearance Since the 1990s, viral clearance (VC) studies have been a critical safety step for biologic drugs.
Partner Content Partner Content LEAN Cell & Gene Summit Boston Manufacturing Advanced Therapies Just in Time for All Patients
R&D Cell therapy transportation and storage with hydrogels Hydrogels are revolutionising cell therapy storage – discover how they tackle cold chain challenges and reduce costs while preserving cell viability.
R&D Sponsored Webinar recap: The future of cell and gene therapy in rare d... For decades, treatment options for rare diseases have been limited, often focusing on symptom management rather than addressing the root cause of them
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
